RxNorm Semantic Concepts Index - 325
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "325".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 3251 | Desmopressin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3251 | Desmopressin | Designated preferred name (PT) | YES | |
| RxCUI: 3251 | Desmopressin | Full form of descriptor (FN) | YES | |
| RxCUI: 3251 | Desmopressin | Designated preferred name (PT) | YES | |
| RxCUI: 3251 | Desmopressin | Full form of descriptor (FN) | YES | |
| RxCUI: 32521 | rocuronium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 32521 | rocuronium bromide | Designated preferred name (PT) | YES | |
| RxCUI: 32521 | rocuronium bromide | Full form of descriptor (FN) | YES | |
| RxCUI: 32526 | ontosein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32526 | ontosein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 32526 | ontosein | Designated preferred name (PT) | NO | |
| RxCUI: 32526 | ontosein | Full form of descriptor (FN) | NO | |
| RxCUI: 32533 | ormetoprim | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 32537 | Ornithine cyclodeaminase | Designated preferred name (PT) | NO | |
| RxCUI: 32537 | Ornithine cyclodeaminase | Full form of descriptor (FN) | NO | |
| RxCUI: 325385 | Antibody to calcium channel | Designated preferred name (PT) | NO | |
| RxCUI: 325385 | Antibody to calcium channel | Full form of descriptor (FN) | NO | |
| RxCUI: 3254 | Desonide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3254 | Desonide | Designated preferred name (PT) | YES | |
| RxCUI: 3254 | Desonide | Full form of descriptor (FN) | YES | |
| RxCUI: 3254 | Desonide | Designated preferred name (PT) | YES | |
| RxCUI: 3254 | Desonide | Full form of descriptor (FN) | YES | |
| RxCUI: 32541 | Ornithine aspartate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32541 | Ornithine aspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 3255 | Desoxymethasone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3255 | Desoxymethasone | Designated preferred name (PT) | YES | |
| RxCUI: 3255 | Desoxymethasone | Full form of descriptor (FN) | YES | |
| RxCUI: 3255 | Desoxymethasone | Designated preferred name (PT) | YES | |
| RxCUI: 3255 | Desoxymethasone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3255 | Desoxymethasone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3255 | Desoxymethasone | Full form of descriptor (FN) | YES | |
| RxCUI: 325514 | indigo disulfonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 325514 | indigo disulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325517 | phenylehrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325518 | trimethoxybenzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325519 | potassium estrone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325520 | potassium oxyquinolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325521 | thyroid (beef) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325522 | tissue respiratory factor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325524 | garlic powder | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325526 | Ginseng extract | Designated preferred name (PT) | YES | |
| RxCUI: 325526 | Ginseng extract | Full form of descriptor (FN) | YES | |
| RxCUI: 325526 | Ginseng extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 325527 | cilantro extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 325527 | cilantro extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32555 | OAF | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32555 | OAF | Designated preferred name (PT) | NO | |
| RxCUI: 32555 | OAF | Full form of descriptor (FN) | NO | |
| RxCUI: 32557 | Osteopontin | Designated preferred name (PT) | NO | |
| RxCUI: 32557 | Osteopontin | Full form of descriptor (FN) | NO | |
| RxCUI: 32559 | sodium oleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 32559 | sodium oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Designated preferred name (PT) | NO | |
| RxCUI: 3256 | 11-deoxycorticosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 3256 | 11-deoxycorticosterone | Designated preferred name (PT) | NO | |
| RxCUI: 3256 | 11-deoxycorticosterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3256 | 11-deoxycorticosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 325642 | ertapenem | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 325642 | ertapenem | Designated preferred name (PT) | YES | |
| RxCUI: 325642 | ertapenem | Full form of descriptor (FN) | YES | |
| RxCUI: 325642 | ertapenem | Designated preferred name (PT) | YES | |
| RxCUI: 325642 | ertapenem | Full form of descriptor (FN) | YES | |
| RxCUI: 325646 | aliskiren | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 325646 | aliskiren | Designated preferred name (PT) | YES | |
| RxCUI: 325646 | aliskiren | Full form of descriptor (FN) | YES | |
| RxCUI: 325646 | aliskiren | Designated preferred name (PT) | YES | |
| RxCUI: 325646 | aliskiren | Full form of descriptor (FN) | YES | |
| RxCUI: 32587 | Oxalate decarboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 32587 | Oxalate decarboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 32588 | Oxalate oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 32588 | Oxalate oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 325887 | micafungin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 325887 | micafungin | Designated preferred name (PT) | YES | |
| RxCUI: 325887 | micafungin | Full form of descriptor (FN) | YES | |
| RxCUI: 325887 | micafungin | Designated preferred name (PT) | YES | |
| RxCUI: 325887 | micafungin | Full form of descriptor (FN) | YES | |
| RxCUI: 32592 | oxaliplatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 32592 | oxaliplatin | Designated preferred name (PT) | YES | |
| RxCUI: 32592 | oxaliplatin | Full form of descriptor (FN) | YES | |
| RxCUI: 32592 | oxaliplatin | Designated preferred name (PT) | YES | |
| RxCUI: 32592 | oxaliplatin | Full form of descriptor (FN) | YES | |
| RxCUI: 32593 | Oxaloacetase | Designated preferred name (PT) | NO | |
| RxCUI: 32593 | Oxaloacetase | Full form of descriptor (FN) | NO | |
| RxCUI: 32594 | Oxalase beta-decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32594 | Oxalase beta-decarboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 32594 | Oxalase beta-decarboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 32595 | Oxaloacetate tautomerase | Designated preferred name (PT) | NO | |
| RxCUI: 32595 | Oxaloacetate tautomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 32598 | Oxalyl-coenzyme A decarboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 32598 | Oxalyl-coenzyme A decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32598 | Oxalyl-coenzyme A decarboxylase | Full form of descriptor (FN) | NO |